Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Nov;140(5):924-6.
doi: 10.1016/j.ajo.2005.05.002.

The three-year incidence of age-related macular degeneration: the "Pathologies Oculaires Liées à l'Age" (POLA) prospective study

Cécile Delcourt  1 , Annie Lacroux, Isabelle Carrière; POLA Study Group
Affiliations

The three-year incidence of age-related macular degeneration: the "Pathologies Oculaires Liées à l'Age" (POLA) prospective study

Cécile Delcourt et al. Am J Ophthalmol. 2005 Nov.

Abstract

Purpose: To assess the 3-year incidence of age-related macular degeneration (AMD) in a French population.

Design: The "Pathologies Oculaires Liées à l'Age" (POLA) Study, a population-based prospective cohort study.

Methods: Retinal photographs were graded according to the international classification. Early age-related maculopathy (ARM) was defined by the presence of (1) soft indistinct drusen (>125 microm) and/or (2) soft distinct drusen (>125 microm) associated with pigmentary abnormalities.

Results: The 3-year incidence of AMD was 0.49% (95% confidence interval [CI]: 0.13 to 0.85) and increased significantly with age, reaching 3.41% (95% CI: 0 to 7.2) in participants aged 80 years or more. After adjustment for age, eyes with early ARM at baseline were 78 times more at risk of developing AMD than eyes without early ARM (OR = 78.4, 95% CI: 14.6 to 420.1).

Conclusions: This study confirms that AMD develops mainly in subjects aged 80 years or older, and in subjects with early ARM.

PubMed Disclaimer

Publication types

LinkOut - more resources